Rhino Swab only contributed 3 M to earnings so plenty of room for growth there with limited extra expenditure required. If the Mute side can continue its trajectory then with Rhino swab staring to add value I can see CFP happening next quarter easily. I also think Rhino swab has legs beyond covid and into respiratory testing in general so does the company so its a good slow burner.
What I like most is that they havnt forgotten their core product (mute) and still see value in this alone. I still believe Rhino swab will take over this in earnings but Mute should be a great base to build this on.
Now we just need the share price to move!
- Forums
- ASX - By Stock
- RNO
- Ann: Preliminary Final Report
Ann: Preliminary Final Report, page-5
-
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RNO (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
BM8
BATTERY AGE MINERALS LTD
Nigel Broomham, CEO
Nigel Broomham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online